Shares of Encompass Health Rise After Strong 1Q; Company Lifts Full-Year Guidance

Dow Jones
04-26
 

By Roshan Fernandez

 

Shares of Encompass Health advanced after the company increased its revenue guidance and reported first-quarter results that topped analysts' expectations.

Shares rose 11% to $112.73 on Friday, a 52-week high. The stock is up 22% year to date.

The provider of inpatient rehabilitative services on Thursday reported net income of $151.5 million, or $1.48 a share, compared with $112.5 million, or $1.10 a share, a year earlier.

Adjusting for one-time items, earnings per share were $1.37, above the $1.19 that analysts polled by FactSet were expecting.

Revenue was $1.46 billion, up from $1.32 billion during the same period last year. Analysts were expecting $1.43 billion.

The Birmingham, Ala.-based company raised its full-year guidance, and now expects revenue between $5.85 billion and $5.93 billion. Its previous guidance was between $5.8 and $5.9 billion.

Its full-year adjusted earnings per share are now expected to be between $4.85 and $5.10, the company said. The company previously had expected between $4.67 and $4.96.

Encompass Health also said it has promoted Patrick Tuer to the newly created role of chief operating officer.

 

Write to Roshan Fernandez at roshan.fernandez@wsj.com

 

(END) Dow Jones Newswires

April 25, 2025 12:57 ET (16:57 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10